Work

Table S1 from Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials

Year: 2023
Type: other
Abstract: Lymphodepletion regimens received by the HCC patients
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361816545
Cites:
Cited by:
Related to: 10